Precigen (PGEN) News Today $4.55 -0.04 (-0.87%) Closing price 04:00 PM EasternExtended Trading$4.58 +0.03 (+0.64%) As of 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Precigen (PGEN) Is Up 32.3% After FDA Approval of First Therapy for Recurrent Respiratory PapillomatosisAugust 27 at 9:53 AM | finance.yahoo.comCitizens JMP Raises PT on Precigen from $6 to $8, Keeps Outperform RatingAugust 26 at 10:13 AM | insidermonkey.comH.C. Wainwright Remains Bullish on Precigen (PGEN)August 26 at 4:57 AM | finance.yahoo.comPrecigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. WainwrightAugust 25 at 8:05 AM | prnewswire.comAnalysts Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $8.25August 24, 2025 | americanbankingnews.comPrecigen Inc. (PGEN) Stock Price Today - WSJAugust 22, 2025 | wsj.comCantor Fitzgerald Cuts Earnings Estimates for PrecigenAugust 22, 2025 | marketbeat.comPrecigen Target of Unusually High Options Trading (NASDAQ:PGEN)August 22, 2025 | americanbankingnews.comPrecigen (NASDAQ:PGEN) Trading Up 10.9% After Analyst UpgradeAugust 21, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAugust 21, 2025 | marketbeat.comPrecigen (PGEN) Gets a Buy from Cantor FitzgeraldAugust 21, 2025 | theglobeandmail.comPrecigen (NASDAQ:PGEN) Given New $8.00 Price Target at JMP SecuritiesAugust 21, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Earns Buy Rating from HC WainwrightAugust 21, 2025 | marketbeat.comFY2026 EPS Estimates for Precigen Decreased by AnalystAugust 21, 2025 | americanbankingnews.comPrecigen files to sell 143.81M shares of common stock for holdersAugust 20, 2025 | msn.comPrecigen (NASDAQ:PGEN) Sees Large Volume Increase - Still a Buy?August 20, 2025 | marketbeat.comMill Creek Capital Advisors LLC Grows Stock Position in Precigen, Inc. $PGENAugust 20, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Given Buy Rating at HC WainwrightAugust 20, 2025 | americanbankingnews.comJMP Securities Issues Positive Forecast for Precigen (NASDAQ:PGEN) Stock PriceAugust 20, 2025 | americanbankingnews.comPrecigen (NASDAQ:PGEN) Trading 10.9% Higher After Analyst UpgradeAugust 20, 2025 | americanbankingnews.comPrecigen (PGEN) Secures FDA Approval for Papillomatosis TreatmentAugust 19, 2025 | insidermonkey.comCitizens JMP Reaffirms Their Buy Rating on Precigen (PGEN)August 19, 2025 | theglobeandmail.comPrecigen (PGEN) Secures FDA Approval for Papillomatosis TreatmentAugust 19, 2025 | msn.comPromising Penny Stocks To Consider - August 17thAugust 19, 2025 | marketbeat.comPrecigen price target raised to $8 from $6 at Citizens JMPAugust 19, 2025 | msn.comFY2025 EPS Estimates for Precigen Reduced by HC WainwrightAugust 19, 2025 | marketbeat.comPrecigen Enters Commercial Supply Agreement with CatalentAugust 18, 2025 | tipranks.comPenny Stocks To Watch Today - August 16thAugust 18, 2025 | marketbeat.comPrecigen’s PAPZIMEOS Receives FDA Approval for RRPAugust 18, 2025 | msn.comPrecigen (NASDAQ:PGEN) Stock Rating Upgraded by JPMorgan Chase & Co.August 18, 2025 | americanbankingnews.comTop Penny Stocks To Watch Today - August 15thAugust 17, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Sets New 1-Year High - Here's What HappenedAugust 17, 2025 | marketbeat.comHC Wainwright Issues Negative Outlook for Precigen EarningsAugust 17, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Rating Increased to Neutral at JPMorgan Chase & Co.August 17, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Precigen Q3 Earnings?August 16, 2025 | marketbeat.comPrecigen surges on FDA approval for immunotherapyAugust 16, 2025 | msn.comPrecigen stock soars after FDA approves first RRP treatmentAugust 16, 2025 | investing.comJP Morgan Upgrades Precigen (PGEN)August 16, 2025 | msn.comPrecigen shares jump after US FDA approves first therapy for rare respiratory diseaseAugust 16, 2025 | msn.comPrecigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos TherapyAugust 16, 2025 | msn.comPrecigen: This Billion-Dollar Approval Is Still UndervaluedAugust 15, 2025 | seekingalpha.comPrecigen, Inc. Stock (PGEN) Opinions on FDA Approval of PapzimeosAugust 15, 2025 | quiverquant.comQPrecigen (NASDAQ:PGEN) Shares Up 7.5% After Better-Than-Expected EarningsAugust 15, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Precigen (NASDAQ:PGEN)August 15, 2025 | marketbeat.comUS FDA approves Precigen's immunotherapy for rare respiratory diseaseAugust 15, 2025 | reuters.comPrecigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory PapillomatosisAugust 15, 2025 | prnewswire.comPrecigen trading halted, news pendingAugust 14, 2025 | msn.comPrecigen (NASDAQ:PGEN) Releases Earnings Results, Beats Estimates By $0.03 EPSAugust 14, 2025 | marketbeat.comPrecigen, Inc. Reports Q2 2025 Earnings and Strategic FocusAugust 13, 2025 | msn.comTraders Buy High Volume of Call Options on Precigen (NASDAQ:PGEN)August 7, 2025 | marketbeat.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.420.99▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼93▲PGEN Articles Average Week Get the Latest News and Ratings for PGEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Precigen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TGTX News Today CYTK News Today ACAD News Today KRYS News Today TLX News Today ADMA News Today AAPG News Today PCVX News Today PTCT News Today LNTH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access